Karl Landsteiner University Publishes Review on Biliary Tract Cancer Treatment

Researchers at Karl Landsteiner University (KL) have published a review on systemic treatments for biliary tract cancer in the journal Therapeutic Advances in Medical Oncology. The research team, led by Dr. Hossein Taghizadeh, examines the use of neoadjuvant therapies, palliative systemic approaches, and novel treatment concepts.

The publication covers treatment modalities that could improve patient outcomes in the future. Biliary tract cancer is currently among the cancers with the poorest prognosis.

The study specifically addresses neoadjuvant therapy, administered before surgery, and palliative care aimed at symptom management. Emerging treatment options, already implemented in select cases, are also assessed for their potential.

Dr. Taghizadeh is affiliated with the Division of Internal Medicine 1 at St. Pölten University Hospital. This publication contributes to the university's ongoing research into advancing cancer therapies.